Fig. 4From: High-resolution metabolomics-based biomarker discovery using exhaled breath condensate from patients with lung cancerPathway identification results with 89 significantly different metabolites using MetaboAnalyst. (healthy controls vs. patients with lung cancer). Pathway impact value (x-axis) from pathway topology analysis and p-values from pathway enrichment analysis (y-axis) are shownBack to article page